Resmed CDI (ASX:RMD)
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) passive income
Resmed CDI (ASX:RMD) share price news
The Resmed CDI (ASX:RMD) share price and CSL Limited (ASX:CSL) share price are worth watching
The Resmed CDI (ASX:RMD) share price is down around 21.8% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price top value?’
The Woolworths Group Ltd (ASX:WOW) share price and Resmed CDI (ASX:RMD) share price are worth watching
The Woolworths Group Ltd (ASX:WOW) share price has risen 4.3% since the start of the 2023. It’s probably worth asking, ‘is the WOW share price top value?’
RMD and CSL Limited: 2 ASX shares to dig into
The Resmed CDI (ASX:RMD) share price has decreased 23.1% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price good value?’
WOW and Resmed CDI: 2 ASX shares for your watchlist
The Woolworths Group Ltd (ASX:WOW) share price is up 3.9% since the start of the 2023. It’s probably worth asking, ‘is the WOW share price good value?’
The Resmed CDI (ASX:RMD) share price and CSL Limited (ASX:CSL) share price are worth watching
The Resmed CDI (ASX:RMD) share price is down around 25.0% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price top value?’
The Woolworths Group Ltd (ASX:WOW) share price and Resmed CDI (ASX:RMD) share price are worth watching
The Woolworths Group Ltd (ASX:WOW) share price has risen 6.7% since the start of the 2023. It’s probably worth asking, ‘is the WOW share price top value?’
RMD and CSL Limited: 2 ASX shares for your watchlist
The Resmed CDI (ASX:RMD) share price has decreased 23.3% since the start of the 2023. It’s probably worth asking, ‘is the RMD share price good value?’
Waiting on a rates decision
The S&P/ASX 200 (INDEXASX: XJO) closed 19.2 points, or 0.3%, higher at 6,997 and the broader All Ordinaries (INDEXASX: XAO) index was 0.2% higher, up 17.2 points at 7,192.3.
Healthcare finds some form ahead of the RBA tomorrow
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.28% to 6997.40.